Stem Cell Transplantation
Recombinant G-CSF aids post-transplant recovery
Published in Blood Weekly, September 19th, 2002
Taner Demirer and colleagues at Ankara Numune Research Hospital and other institutions in Ankara, Gazi, Mersin, and Hacettepe "evaluated the effect of post-transplant recombinant human granulocyte colony-stimulating factor (rhG-CSF) administration on the parameters of peritransplant morbidity."
Treatment with rhG-CSF hastened hematological recovery and attenuated peritransplant morbidity, Demirer and coauthors found.
The researchers compared transplant...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2002-09-19)
More Articles from Blood Weekly
- Blood Testing
Skin antisepsis kits reduce blood sample contamination - Hematopoiesis
Preemptive lamivudine inhibits hepatitis B effects after transplantation - Stem Cell Transplantation
Plasminogen activator inhibitor-1 marks post-transplant, veno-occlusive disease - Transfusion Medicine
Self-donation of blood before surgery may not always benefit hip replacement patients - Anemia
Drug reduces transfusions and chemotherapy-related fatigue - Anemia
Hemopure marketing application submitted to FDA - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
